These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 14599111

  • 1. Two cases of monostotic Paget's disease: effects of bisphosphonate.
    Hoshiro M, Harada T, Iwai H, Miyatake T, Nishimura A, Ohno Y, Aoki N.
    Endocr J; 2003 Aug; 50(4):385-92. PubMed ID: 14599111
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA, Altayar O, BenKhadra K, Qasim Agha OQ, Asi N, Nabhan M, Prokop LJ, Tebben P, Murad MH.
    Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
    Muschitz C, Feichtinger X, Haschka J, Kocijan R.
    Wien Med Wochenschr; 2017 Feb; 167(1-2):18-24. PubMed ID: 27600563
    [Abstract] [Full Text] [Related]

  • 5. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH.
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [Abstract] [Full Text] [Related]

  • 6. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
    Roux C, Gennari C, Farrerons J, Devogelaer JP, Mulder H, Kruse HP, Picot C, Titeux L, Reginster JY, Dougados M.
    Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
    [Abstract] [Full Text] [Related]

  • 7. Risedronate: a new oral bisphosphonate.
    Umland EM, Boyce EG.
    Clin Ther; 2001 Sep; 23(9):1409-21. PubMed ID: 11589256
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic strategy in Paget's disease of bone.
    Meunier PJ, Vignot E.
    Bone; 1995 Nov; 17(5 Suppl):489S-491S. PubMed ID: 8573424
    [Abstract] [Full Text] [Related]

  • 9. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
    Whitson HE, Lobaugh B, Lyles KW.
    Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
    [Abstract] [Full Text] [Related]

  • 10. A patient with Paget's disease of bone treated with etidronate disodium.
    Koga K, Kawasaki K, Kohno S, Yamada K, Itoh T, Nonaka K.
    Kurume Med J; 1998 Oct; 45(4):345-9. PubMed ID: 9914722
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.
    Drake WM, Kendler DL, Brown JP.
    Clin Ther; 2001 Apr; 23(4):620-6. PubMed ID: 11354395
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial.
    Reid IR, Nicholson GC, Weinstein RS, Hosking DJ, Cundy T, Kotowicz MA, Murphy WA, Yeap S, Dufresne S, Lombardi A, Musliner TA, Thompson DE, Yates AJ.
    Am J Med; 1996 Oct; 101(4):341-8. PubMed ID: 8873503
    [Abstract] [Full Text] [Related]

  • 15. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR, Ibbertson HK, Holdaway IM, Rutland M, King A, Dodd G, Wattie DJ.
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Stuckey BG, Lim EM, Kent GN, Ward LC, Gutteridge DH.
    J Bone Miner Res; 2001 Sep; 16(9):1719-23. PubMed ID: 11547843
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M, Khairi A, Johnston C.
    Clin Orthop Relat Res; 1977 Sep; (127):94-105. PubMed ID: 410576
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A, Mermillod B, Schenk R, Courvoisier B, Burkhardt P, Epiney J, Fleisch.
    Schweiz Med Wochenschr; 1976 Nov 27; 106(48):1667-73. PubMed ID: 827810
    [Abstract] [Full Text] [Related]

  • 19. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D.
    N Engl J Med; 2005 Sep 01; 353(9):898-908. PubMed ID: 16135834
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
    Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ.
    Am J Med; 1999 May 01; 106(5):513-20. PubMed ID: 10335722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.